drugset
Drugs / Live Attenuated Varicella Vaccine
last change Oct 2025 re-read 2 minutes ago

Live Attenuated Varicella Vaccine

also known as VarV

Vaccine

Developed for
chickenpox
Investigated by
Sinovac (Dalian) Vaccine Technology Co., Ltd. · Guangdong Provincial Institute of Biological Products And Materia Medica · Changchun Keygen Biological Products Co., Ltd. · Beijing Institute of Biological Products Co Ltd. · Changchun Changsheng Life Science and Technology Co., Ltd. · China National Biotec Group Company Limited
+1 more · Jiangsu Province Centers for Disease Control and Prevention

Trials 10 · a red edge is where a trial was stopped

today NCT06484686 · Ph 4 NCT05669625 · Ph 3 NCT05460429 · Ph 4 NCT05470855 · Ph 4 NCT05095701 · Ph 4 NCT05526820 · Ph 4 NCT02981836 · Ph 3 NCT01982409 · Ph 4 NCT01815073 · Ph 4 NCT01817270 · Ph 4
20132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 32 trials
Phase 3 NCT05669625 Dec 2022 → Apr 2024 overdue chickenpox China National Biotec Group Company Limited Active not recruiting No outcome recorded
Phase 3 NCT02981836 Aug 2016 → Jun 2017 chickenpox Sinovac (Dalian) Vaccine Technology Co., Ltd. Completed No outcome recorded
Phase 48 trials
Phase 4 NCT06484686 Sep 2024 → Dec 2028 expected chickenpox Sinovac (Dalian) Vaccine Technology Co., Ltd. Enrolling by invitation No outcome recorded
Phase 4 NCT05460429 Jul 2022 → Mar 2023 chickenpox Sinovac (Dalian) Vaccine Technology Co., Ltd. Unknown No outcome recorded
Phase 4 NCT05470855 Jul → Nov 2022 chickenpox Sinovac (Dalian) Vaccine Technology Co., Ltd. Unknown No outcome recorded
Phase 4 NCT05095701 Dec 2021 overdue chickenpox Sinovac (Dalian) Vaccine Technology Co., Ltd. Enrolling by invitation No outcome recorded
Phase 4 NCT05526820 Apr 2021 chickenpox Sinovac (Dalian) Vaccine Technology Co., Ltd. Completed No outcome recorded
Phase 4 NCT01982409 Jun 2013 → Jan 2018 chickenpox Changchun Changsheng Life Science and Technology Co., Ltd. Unknown No outcome recorded
Phase 4 NCT01815073 Mar → Jul 2013 Japanese encephalitis, chickenpox Changchun Keygen Biological Products Co., Ltd. Completed No outcome recorded
Phase 4 NCT01817270 Mar → Aug 2013 chickenpox Changchun Keygen Biological Products Co., Ltd. Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03555071 Comparator Apr 2014 → May 2017 chickenpox Sinovac (Dalian) Vaccine Technology Co., Ltd. Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 13 sources stand behind the page.

FieldValueCited text
Known as Live Attenuated Varicella Vaccine “Single subcutaneous injection of the investigated live attenuated varicella vaccine (0.5 ml) on Day 0” NCT03555071 ↗
10

NCT01982409 ↗

NCT02981836 ↗

NCT05526820 ↗

NCT05470855 ↗

NCT05460429 ↗

NCT01815073 ↗

NCT05669625 ↗

NCT06484686 ↗

NCT05095701 ↗

NCT01817270 ↗
Known as VarV “AIM: To evaluate the immunogenicity and safety of a booster dose of live attenuated varicella vaccine (VarV) manufactured by Sinovac (Dalian) Vaccine Technology Co. Ltd., and...” PMID 35632416 ↗ Apr 2022
1

“This study aimed to evaluate the immunogenicity and safety of co-administration with live attenuated varicella vaccine (VarV) and inactivated hepatitis A vaccine (HepA) among...” PMID 36593652 ↗ Jan 2023
Modality Vaccine “Live Attenuated Varicella Vaccine” NCT01815073 ↗
Route Other “the hypodermic injection” NCT01817270 ↗